List of Tables
Table 1. Global Interchangeable Biosimilar Humira Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Interchangeable Biosimilar Humira Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Interchangeable Biosimilar Humira Market Competitive Situation by Manufacturers in 2024
Table 4. Global Interchangeable Biosimilar Humira Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Interchangeable Biosimilar Humira Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Interchangeable Biosimilar Humira Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Interchangeable Biosimilar Humira Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Interchangeable Biosimilar Humira Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Interchangeable Biosimilar Humira, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Interchangeable Biosimilar Humira, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Interchangeable Biosimilar Humira, Product Type & Application
Table 12. Global Key Manufacturers of Interchangeable Biosimilar Humira, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Interchangeable Biosimilar Humira by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Interchangeable Biosimilar Humira as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Interchangeable Biosimilar Humira Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Interchangeable Biosimilar Humira Sales by Region (2020-2025) & (K Units)
Table 18. Global Interchangeable Biosimilar Humira Sales Market Share by Region (2020-2025)
Table 19. Global Interchangeable Biosimilar Humira Sales by Region (2026-2031) & (K Units)
Table 20. Global Interchangeable Biosimilar Humira Sales Market Share by Region (2026-2031)
Table 21. Global Interchangeable Biosimilar Humira Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Interchangeable Biosimilar Humira Revenue Market Share by Region (2020-2025)
Table 23. Global Interchangeable Biosimilar Humira Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Interchangeable Biosimilar Humira Revenue Market Share by Region (2026-2031)
Table 25. North America Interchangeable Biosimilar Humira Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Interchangeable Biosimilar Humira Sales by Country (2020-2025) & (K Units)
Table 27. North America Interchangeable Biosimilar Humira Sales by Country (2026-2031) & (K Units)
Table 28. North America Interchangeable Biosimilar Humira Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Interchangeable Biosimilar Humira Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Interchangeable Biosimilar Humira Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Interchangeable Biosimilar Humira Sales by Country (2020-2025) & (K Units)
Table 32. Europe Interchangeable Biosimilar Humira Sales by Country (2026-2031) & (K Units)
Table 33. Europe Interchangeable Biosimilar Humira Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Interchangeable Biosimilar Humira Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Interchangeable Biosimilar Humira Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Interchangeable Biosimilar Humira Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Interchangeable Biosimilar Humira Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Interchangeable Biosimilar Humira Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Interchangeable Biosimilar Humira Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Interchangeable Biosimilar Humira Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Interchangeable Biosimilar Humira Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Interchangeable Biosimilar Humira Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Interchangeable Biosimilar Humira Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Interchangeable Biosimilar Humira Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Interchangeable Biosimilar Humira Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Interchangeable Biosimilar Humira Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Interchangeable Biosimilar Humira Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Interchangeable Biosimilar Humira Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Interchangeable Biosimilar Humira Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Interchangeable Biosimilar Humira Sales (K Units) by Type (2020-2025)
Table 51. Global Interchangeable Biosimilar Humira Sales (K Units) by Type (2026-2031)
Table 52. Global Interchangeable Biosimilar Humira Sales Market Share by Type (2020-2025)
Table 53. Global Interchangeable Biosimilar Humira Sales Market Share by Type (2026-2031)
Table 54. Global Interchangeable Biosimilar Humira Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Interchangeable Biosimilar Humira Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Interchangeable Biosimilar Humira Revenue Market Share by Type (2020-2025)
Table 57. Global Interchangeable Biosimilar Humira Revenue Market Share by Type (2026-2031)
Table 58. Global Interchangeable Biosimilar Humira Price (US$/Unit) by Type (2020-2025)
Table 59. Global Interchangeable Biosimilar Humira Price (US$/Unit) by Type (2026-2031)
Table 60. Global Interchangeable Biosimilar Humira Sales (K Units) by Application (2020-2025)
Table 61. Global Interchangeable Biosimilar Humira Sales (K Units) by Application (2026-2031)
Table 62. Global Interchangeable Biosimilar Humira Sales Market Share by Application (2020-2025)
Table 63. Global Interchangeable Biosimilar Humira Sales Market Share by Application (2026-2031)
Table 64. Global Interchangeable Biosimilar Humira Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Interchangeable Biosimilar Humira Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Interchangeable Biosimilar Humira Revenue Market Share by Application (2020-2025)
Table 67. Global Interchangeable Biosimilar Humira Revenue Market Share by Application (2026-2031)
Table 68. Global Interchangeable Biosimilar Humira Price (US$/Unit) by Application (2020-2025)
Table 69. Global Interchangeable Biosimilar Humira Price (US$/Unit) by Application (2026-2031)
Table 70. Samsung Bioepis Co., Ltd. Company Information
Table 71. Samsung Bioepis Co., Ltd. Description and Business Overview
Table 72. Samsung Bioepis Co., Ltd. Interchangeable Biosimilar Humira Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Samsung Bioepis Co., Ltd. Interchangeable Biosimilar Humira Product
Table 74. Samsung Bioepis Co., Ltd. Recent Developments/Updates
Table 75. Sandoz International GmbH (Novartis AG) Company Information
Table 76. Sandoz International GmbH (Novartis AG) Description and Business Overview
Table 77. Sandoz International GmbH (Novartis AG) Interchangeable Biosimilar Humira Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Sandoz International GmbH (Novartis AG) Interchangeable Biosimilar Humira Product
Table 79. Sandoz International GmbH (Novartis AG) Recent Developments/Updates
Table 80. Mylan N.V. Company Information
Table 81. Mylan N.V. Description and Business Overview
Table 82. Mylan N.V. Interchangeable Biosimilar Humira Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Mylan N.V. Interchangeable Biosimilar Humira Product
Table 84. Mylan N.V. Recent Developments/Updates
Table 85. Boehringer Ingelheim International GmbH Company Information
Table 86. Boehringer Ingelheim International GmbH Description and Business Overview
Table 87. Boehringer Ingelheim International GmbH Interchangeable Biosimilar Humira Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Boehringer Ingelheim International GmbH Interchangeable Biosimilar Humira Product
Table 89. Boehringer Ingelheim International GmbH Recent Developments/Updates
Table 90. Pfizer Inc. Company Information
Table 91. Pfizer Inc. Description and Business Overview
Table 92. Pfizer Inc. Interchangeable Biosimilar Humira Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Pfizer Inc. Interchangeable Biosimilar Humira Product
Table 94. Pfizer Inc. Recent Developments/Updates
Table 95. Fresenius Kabi AG Company Information
Table 96. Fresenius Kabi AG Description and Business Overview
Table 97. Fresenius Kabi AG Interchangeable Biosimilar Humira Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Fresenius Kabi AG Interchangeable Biosimilar Humira Product
Table 99. Fresenius Kabi AG Recent Developments/Updates
Table 100. Coherus BioSciences, Inc. Company Information
Table 101. Coherus BioSciences, Inc. Description and Business Overview
Table 102. Coherus BioSciences, Inc. Interchangeable Biosimilar Humira Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Coherus BioSciences, Inc. Interchangeable Biosimilar Humira Product
Table 104. Coherus BioSciences, Inc. Recent Developments/Updates
Table 105. Biogen Inc. Company Information
Table 106. Biogen Inc. Description and Business Overview
Table 107. Biogen Inc. Interchangeable Biosimilar Humira Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Biogen Inc. Interchangeable Biosimilar Humira Product
Table 109. Biogen Inc. Recent Developments/Updates
Table 110. AbbVie Inc. Company Information
Table 111. AbbVie Inc. Description and Business Overview
Table 112. AbbVie Inc. Interchangeable Biosimilar Humira Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. AbbVie Inc. Interchangeable Biosimilar Humira Product
Table 114. AbbVie Inc. Recent Developments/Updates
Table 115. Celltrion Inc. Company Information
Table 116. Celltrion Inc. Description and Business Overview
Table 117. Celltrion Inc. Interchangeable Biosimilar Humira Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Celltrion Inc. Interchangeable Biosimilar Humira Product
Table 119. Celltrion Inc. Recent Developments/Updates
Table 120. Amneal Pharmaceuticals, Inc. Company Information
Table 121. Amneal Pharmaceuticals, Inc. Description and Business Overview
Table 122. Amneal Pharmaceuticals, Inc. Interchangeable Biosimilar Humira Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Amneal Pharmaceuticals, Inc. Interchangeable Biosimilar Humira Product
Table 124. Amneal Pharmaceuticals, Inc. Recent Developments/Updates
Table 125. Lupin Pharmaceuticals, Inc. Company Information
Table 126. Lupin Pharmaceuticals, Inc. Description and Business Overview
Table 127. Lupin Pharmaceuticals, Inc. Interchangeable Biosimilar Humira Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Lupin Pharmaceuticals, Inc. Interchangeable Biosimilar Humira Product
Table 129. Lupin Pharmaceuticals, Inc. Recent Developments/Updates
Table 130. Merck & Co., Inc. Company Information
Table 131. Merck & Co., Inc. Description and Business Overview
Table 132. Merck & Co., Inc. Interchangeable Biosimilar Humira Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Merck & Co., Inc. Interchangeable Biosimilar Humira Product
Table 134. Merck & Co., Inc. Recent Developments/Updates
Table 135. Viatris Inc.imilar Company Information
Table 136. Viatris Inc.imilar Description and Business Overview
Table 137. Viatris Inc.imilar Interchangeable Biosimilar Humira Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Viatris Inc.imilar Interchangeable Biosimilar Humira Product
Table 139. Viatris Inc.imilar Recent Developments/Updates
Table 140. Amgen Inc. Company Information
Table 141. Amgen Inc. Description and Business Overview
Table 142. Amgen Inc. Interchangeable Biosimilar Humira Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Amgen Inc. Interchangeable Biosimilar Humira Product
Table 144. Amgen Inc. Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Interchangeable Biosimilar Humira Distributors List
Table 148. Interchangeable Biosimilar Humira Customers List
Table 149. Interchangeable Biosimilar Humira Market Trends
Table 150. Interchangeable Biosimilar Humira Market Drivers
Table 151. Interchangeable Biosimilar Humira Market Challenges
Table 152. Interchangeable Biosimilar Humira Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Interchangeable Biosimilar Humira
Figure 2. Global Interchangeable Biosimilar Humira Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Interchangeable Biosimilar Humira Market Share by Type: 2024 & 2031
Figure 4. Subcutaneous (SC) Injection Product Picture
Figure 5. Intravenous (IV) Infusion Product Picture
Figure 6. Global Interchangeable Biosimilar Humira Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Interchangeable Biosimilar Humira Market Share by Application: 2024 & 2031
Figure 8. Hospital Pharmacies
Figure 9. Retail Pharmacies
Figure 10. Online Pharmacies
Figure 11. Global Interchangeable Biosimilar Humira Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Interchangeable Biosimilar Humira Market Size (2020-2031) & (US$ Million)
Figure 13. Global Interchangeable Biosimilar Humira Sales (2020-2031) & (K Units)
Figure 14. Global Interchangeable Biosimilar Humira Average Price (US$/Unit) & (2020-2031)
Figure 15. Interchangeable Biosimilar Humira Report Years Considered
Figure 16. Interchangeable Biosimilar Humira Sales Share by Manufacturers in 2024
Figure 17. Global Interchangeable Biosimilar Humira Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Interchangeable Biosimilar Humira Players: Market Share by Revenue in Interchangeable Biosimilar Humira in 2024
Figure 19. Interchangeable Biosimilar Humira Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Interchangeable Biosimilar Humira Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Interchangeable Biosimilar Humira Sales Market Share by Country (2020-2031)
Figure 22. North America Interchangeable Biosimilar Humira Revenue Market Share by Country (2020-2031)
Figure 23. United States Interchangeable Biosimilar Humira Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Interchangeable Biosimilar Humira Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Interchangeable Biosimilar Humira Sales Market Share by Country (2020-2031)
Figure 26. Europe Interchangeable Biosimilar Humira Revenue Market Share by Country (2020-2031)
Figure 27. Germany Interchangeable Biosimilar Humira Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Interchangeable Biosimilar Humira Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Interchangeable Biosimilar Humira Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Interchangeable Biosimilar Humira Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Interchangeable Biosimilar Humira Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Interchangeable Biosimilar Humira Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Interchangeable Biosimilar Humira Revenue Market Share by Region (2020-2031)
Figure 34. China Interchangeable Biosimilar Humira Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Interchangeable Biosimilar Humira Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Interchangeable Biosimilar Humira Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Interchangeable Biosimilar Humira Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Interchangeable Biosimilar Humira Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Interchangeable Biosimilar Humira Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Interchangeable Biosimilar Humira Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Interchangeable Biosimilar Humira Sales Market Share by Country (2020-2031)
Figure 42. Latin America Interchangeable Biosimilar Humira Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Interchangeable Biosimilar Humira Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Interchangeable Biosimilar Humira Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Interchangeable Biosimilar Humira Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa Interchangeable Biosimilar Humira Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Interchangeable Biosimilar Humira Revenue Market Share by Country (2020-2031)
Figure 48. Turkey Interchangeable Biosimilar Humira Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Interchangeable Biosimilar Humira Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE Interchangeable Biosimilar Humira Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of Interchangeable Biosimilar Humira by Type (2020-2031)
Figure 52. Global Revenue Market Share of Interchangeable Biosimilar Humira by Type (2020-2031)
Figure 53. Global Interchangeable Biosimilar Humira Price (US$/Unit) by Type (2020-2031)
Figure 54. Global Sales Market Share of Interchangeable Biosimilar Humira by Application (2020-2031)
Figure 55. Global Revenue Market Share of Interchangeable Biosimilar Humira by Application (2020-2031)
Figure 56. Global Interchangeable Biosimilar Humira Price (US$/Unit) by Application (2020-2031)
Figure 57. Interchangeable Biosimilar Humira Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
